Both Betaserc and Stugeron are used to treat the symptoms of inner ear disorders and vertigo, but they differ in the active ingredients they contain, their mechanism of action, and their specific uses. Understanding these differences helps determine the most appropriate medication for symptom relief.
Betaserc Tablets Ingredients
Betaserc tablets contain the active ingredient betahistine dihydrochloride. Betahistine is a histamine analogue that acts as a partial agonist at histamine H1 receptors and an antagonist at histamine H3 receptors in the inner ear and brain. It is believed to improve blood circulation in the inner ear and reduce pressure buildup, helping relieve the symptoms of vertigo, tinnitus, and hearing loss associated with Meniere's disease.
Stugeron Tablets Ingredients
Stogeron tablets contain the active ingredient cinnarizine. Cinnarizine is an antihistamine and calcium channel blocker. It is primarily used to improve blood circulation in the inner ear and brain and relieve the symptoms of vertigo, dizziness, and balance disorders. It works by preventing constriction of blood vessels in the inner ear and brain, increasing blood flow and improving vestibular function.
About Betaserc Tablets
Drug Category: Drugs for the treatment of vertigo and inner ear disorders
Drug Classification: Histamine Analogues
Pharmaceutical Form: Tablets
Pharmaceutical Family: Central Nervous System Drugs
Active Ingredient: Betahistine Dihydrochloride
About Stugeron Tablets
Drug Category: Drugs for the treatment of vertigo and cerebral and peripheral circulatory disorders
Drug Classification: Antihistamines and Calcium Channel Blockers
Pharmaceutical Form: Tablets
Pharmaceutical Family: Central Nervous System and Peripheral Vascular Drugs
Active Ingredient: Cinnarizine